RT @JNeurooncol: Read about discordances in ER, PR, and HER2 between primary breast cancer and brain metastasis @NSTumorSection #mets #canc…
RT @JNeurooncol: Read about discordances in ER, PR, and HER2 between primary breast cancer and brain metastasis @NSTumorSection #mets #canc…
Read about discordances in ER, PR, and HER2 between primary breast cancer and brain metastasis @NSTumorSection #mets #cancer #genomics https://t.co/3QP84tGQq1 https://t.co/uDLBjeGt0Q
RT @JNeurooncol: #FreeArticle: Concordance in biomarkers (ER, PR, or HER2) expressed by primary breast cancer tumors and brain metastases m…
RT @JNeurooncol: #FreeArticle: Concordance in biomarkers (ER, PR, or HER2) expressed by primary breast cancer tumors and brain metastases m…
RT @JNeurooncol: #FreeArticle: Concordance in biomarkers (ER, PR, or HER2) expressed by primary breast cancer tumors and brain metastases m…
#FreeArticle: Concordance in biomarkers (ER, PR, or HER2) expressed by primary breast cancer tumors and brain metastases may contribute to longer overall survival. https://t.co/3QP84tGQq1 https://t.co/9MbgpcwhBu
Discordances in ER, PR, and HER2 between primary breast cancer and brain metastasis. https://t.co/h5INT9VbMl
Discordances in ER, PR, and HER2 between primary breast cancer and brain metastasis https://t.co/VAlibiihLy